The COVID-19: Global Impact on Clinical Trials visualizer is an interactive learning tool that brings together global clinical trial data to support reflection on how the pandemic affected research activity. It enables users to view trends over time and compare COVID-19–related and non-COVID-19 trials at global and country levels.
The visualizer exists to help clinical, quality, and regulatory professionals examine how trial conduct, focus areas, and reported activity shifted during a period of significant disruption. By structuring the data visually, it supports interpretation of patterns rather than assumptions about performance or causality.
Ways to explore pandemic-related shifts in trials
Compare COVID-19 and Non-COVID-19 Activity
Review Trial Characteristics
Track Trends Across Years
The visualizer is based on publicly available trial records from ClinicalTrials.gov, covering the period from 2015 to 2022. The visual structure focuses on side-by-side comparisons across multiple dimensions, allowing users to explore how reported trial characteristics evolved without implying judgments on quality or outcomes.
What can these comparisons tell you?
Use the visuals to identify patterns and ask informed questions about how global events influenced trial activity, design focus, and reporting trends.
The eyesON series is a collection of interactive visual tools designed to support understanding of complex topics in clinical research and regulation. Each visualizer emphasizes clarity, transparency, and thoughtful exploration of real-world data.
Cyntegrity offers the eyesON series as an educational contribution to the clinical research community, drawing on internal experience in data analysis and regulatory-focused work to make industry data more accessible. Explore More Interactive Visualizers…
See how other datasets can sharpen signal awareness and decision-making.
Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.
Featured Insights
Start Your Roll-Out
Quick Answers
